Roth MKM analyst Darren Aftahi maintained a Buy rating on Core Scientific Inc (CORZ – Research Report) today and set a price target of $23.00.
Incontinence is a common condition. One in four Australian adults need extra support, while bedwetting and accidents can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback